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Abstract
Background: Obtaining single parasite clones is required for many techniques in malaria research. Cloning by
limiting dilution using microscopy-based assessment for parasite growth is an arduous and labor-intensive process.
An alternative method for the detection of parasite growth in limiting dilution assays is using a commercial ELISA
histidine-rich protein II (HRP2) detection kit.
Methods: Detection of parasite growth was undertaken using HRP2 ELISA and compared to thick film microscopy.
An HRP2 protein standard was used to determine the detection threshold of the HRP2 ELISA assay, and a HRP2
release model was used to extrapolate the amount of parasite growth required for a positive result.
Results: The HRP2 ELISA was more sensitive than microscopy for detecting parasite growth. The minimum level of
HRP2 protein detection of the ELISA was 0.11ng/ml. Modeling of HRP2 release determined that 2,116 parasites are
required to complete a full erythrocytic cycle to produce sufficient HRP2 to be detected by the ELISA. Under
standard culture conditions this number of parasites is likely to be reached between 8 to 14 days of culture.
Conclusions: This method provides an accurate and simple way for the detection of parasite growth in limiting
dilution assays, reducing time and resources required in traditional methods. Furthermore the method uses spent
culture media instead of the parasite-infected red blood cells, enabling culture to continue.
Background
The use of single parasite clones is an essential part of
many malaria experimental studies. Techniques requiring
clones include: isolating parasite lines from field samples,
genotyping, drug resistance testing and genetic manipula-
tion [1-3]. These studies require single clonal parasite
isolates to ensure accurate and unambiguous results.
Limiting dilution is the standard method for in vitro
cloning of Plasmodium falciparum isolates. The method
entails the culture of parasites in a 96-well microtiter
plate at dilutions below one parasite per well for 2-4
weeks [4]. At the appropriate dilution, individual clones
grow in a single well. Detecting parasite growth by
microscopic examination of smears in such limiting
dilution assays is time consuming and laborious, thereby
restricting the concurrent analysis of multiple plates [4].
Another popular method is the lactate dehydrogenase
assay (pLDH) [5]. While this technique is simple to use,
it requires that parasitized red blood cells be tested,
thereby further attenuating parasite culture. Other
methods of detection that have been described include
PCR and flow cytometery, both of which require specia-
list equipment and knowledge [6-8].
Histidine-rich protein II (HRP2) is a water-soluble non-
labile protein produced by P. falciparum across the asexual
cycle and is secreted into parasite culture media where it
can be detected by an antigen capture ELISA. HRP2 detec-
tion by ELISA is a fast, accurate method, and only requires
the use of spent culture media ensuring that culture can
continue. In this experiment the detection of HRP2 by
ELISA using a commercially available kit as a means to
facilitate the limiting dilution assay was evaluated.
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Methods
Materials
The following ELISA was used: Malaria Ag. Pf. ELISA
(Standard Diagnostics Korea; product code 05EK50).
Detection of parasites by HRP2 ELISA vs. microscopy
The P. falciparum strain 3D7 was subject to routine in
vitro culture [9]. Asynchronous cultures were evaluated
by microscopy to determine parasitaemia and to ensure
they contained > 90% singly infected erythrocytes. Hae-
matocrit was measured using a haemocytometer. A sus-
pension was prepared that contained 50 parasitized
erythrocytes at a haematocrit of 2% in 10 ml of culture
media. This was plated out at 0.5 parasites per well in a
96 well sterile microtiter plate, adding 100 ul per well.
Three wells of non-parasitized erythrocytes at 2% hae-
matocrit were included as a negative control. Culture
media was changed at days 4, 7, 11, 14 and 18 using a
multichannel pipette. Parasite growth was detected by
HRP2 Antigen (Ag) by ELISA (Standard Diagnostics
Korea) using spent culture media on days 14 and 21.
Assays were performed in accordance with the manufac-
turers instructions with one exception; 50 μl of spent
media was added to 75 μl of conjugate, instead of 100
μl of sample to 150 μl of conjugate. All wells were
assessed by microscope examination of thick smears by
two operators. The data presented here is one represen-
tative experiment of three.
HRP2 antigen quantification
Freshly prepared serial dilutions of 3D7 parasite culture
supernatant taken from a frozen stock were used as
control standards in each ELISA. The concentration of
HRP2 in this culture supernatant had previously been
measured at 55.5 ng/ml. This concentration had been
determined by interpolating the ELISA optical density of
serial dilutions of this culture supernatant against a
stock of recombinant HRP2 protein with known protein
concentration (Nelson Lee, manuscript in preparation).
The HRP2 antigen level in ELISA assays was interpo-
lated from a four parameter standard curve using the
software package Softmax Pro (Molecular Devices Inc.).
The cut-off for a positive result was set at the mean + 3
standard deviations above the red blood cell control
sample optical densities. The threshold for HRP2 detec-
tion was determined in ng/ml and converted to ng/50 μl
to reflect the volume of supernatant tested in the assay.
HRP2 release model and minimum parasite numbers
The minimum parasite number required for detection
was calculated by dividing the HRP2 antigen detection
threshold of the ELISA by the amount of HRP2 pro-
duced per parasite per cycle [10]. A model predicting
the accumulation and release of HRP2 in a well
containing a single parasite over time was derived. The
model was based on a replication rate of 2-10 replica-
tions per cycle with 5.2 fg of HRP2 secreted/parasite/
erythrocytic cycle [10]. The following is the equation
used for the model: HRP2 accumulation = 5.2 fg ×
(replication rate × parasite number of previous genera-
tion). Replications were defined as the number of para-
sites produced by one parasite during one cycle of
asexual reproduction. The ELISA threshold of detection
was doubled to reflect that only half the volume of the
well is used in the ELISA and therefore half the accu-
mulated HRP2 can be detected. This threshold was then
applied to the model and the asexual cycle at which the
threshold would be reached was obtained across a range
of replication rates. The cycle at which the HRP2
threshold would be reached was then converted into
days, assuming a duration of the asexual cycle of 48
hours, beginning at ring forms and ending at schizont
rupture. As this conversion would be affected by using
asynchronous cultures, the estimated day the threshold
of HRP2 accumulation is reached is ± 12 hours the pre-
diction. The model also assumed media changes every
48 hours, which is the length of an asexual cycle.
Results
ELISA vs. microscopy
To compare the sensitivity of the HRP2 antigen ELISA
assay and microscopy, all plate wells were smeared and
assessed. At day 14, 54% (49/91) of the wells were posi-
tive by ELISA, of which two were negative by micro-
scopy (47/91). At Day 21 all wells positive by ELISA
(49/91) were also positive by microscopy (49/91). All
wells negative by ELISA were negative by microscopy.
The ELISA HRP2 detection threshold and HRP2 release
model
The limit of sensitivity of the HRP2 ELISA kit was 0.11
ng/ml (Figure 1). This equates to 5.5 pg of HRP2 in 50
μl of culture supernatant used in the ELISA. As half the
culture supernatant volume of each well in a dilution
plate is used in the assay, 11 pg of HRP2 is required to
accumulate in 100 μl of supernatant to reach a detect-
able level by ELISA. By applying previously published
data indicating that 5.2 fg of HRP2 is released by one
parasite per erythrocytic cycle [10] it follows that 2,116
parasites would be required to complete one erythrocy-
tic cycle in order for HRP2 levels to accumulate to the
detection threshold.
The time point when HRP2 antigen levels in the cul-
tures reach the ELISA detection threshold depends on
the parasite replication rate, as well as the timing of
media changes. HRP2 accumulation has been shown to
correlate directly with parasite growth rate [11]. The
replication/growth rate of parasites depends on many
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factors, such as parasite strain and in vitro culture con-
ditions. In order to determine when a well containing a
single parasite at the start of an experiment would reach
the HRP2 antigen detection threshold, a HRP2 release
model was constructed. In this model the 5.2 fg HRP2
produced per cycle is used in an equation with the pre-
dicted exponential growth rate of between 2-10 replica-
tions per parasite per cycle. In figure 2, a parasite
replication rate of 5 per cycle was applied to the sensi-
tivity index. The model predicts that a single starting
parasite will reach > 2,116 parasites after 5 cycles or 10
days of culture.
The model predicts that at a minimum growth rate of
3 replications per cycle, HRP2 accumulation will reach
the point of detection of the ELISA by day 14 of culture.
Applying a replication rate of 10 per cycle, the positive
wells should be detectable in 8 days. All predictions of
time to reach the detection threshold are, ± 12 hours if
using an asynchronous culture. In the limiting dilution
experiment reported here, all wells containing parasites
were positive by day 14, as predicted by the model.
Discussion
Cloning by limiting dilution is an indispensable method
in malaria research. However, it is time consuming and
labor intensive. The use of a commercial ELISA kit
represents a timesaving alternative method for detection
of P. falciparum growth in such experiments. In addi-
tion, it holds a distinct advantage over other methods,
such as the pLDH assay, as the HRP2 antigen ELISA
uses spent culture media, not parasitized erythrocytes,
thereby ensuring that culture can continue.
Recently described methods of detection, PCR and
flow cytometry, require specialist equipment and trained
operators. The ELISA method is simple and quick to
perform and does not require expensive reagents. The
ease of this method ensues successive plates can be run,
allowing a higher volume of plates to be analyzed at
once. This is in contrast to the traditional method of
microscopy, which is time consuming and relies on the
skills of the operator. Furthermore, 2-week-old cultures
traditionally produce smears that are difficult to read,
containing a large amount of parasite debris. In this
work, microscopy proved to be the least sensitive
method. The HRP2 ELISA described is highly sensitive,
detecting the presence of HRP2 produced by P. falci-
parum parasites in spent culture media at a limit of
detection of 0.11 ng/ml.
The relationship between the ELISA detection thresh-
old and number of parasites is difficult to directly mea-
sure as the method detects the amount of HRP2 antigen
that accumulates over time and thereby depends on the
parasite replication rate. The replication rate of a parasite
depends on many variables, such as culture conditions,
0.
03
12
5
0.
06
25
0.
12
5
0.
25 0.
5 1 2 4 8 16 32
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
ng/ml HRP2
O
pt
ic
al
  D
en
si
ty
Figure 1 HRP2 ELISA Detection Threshold. Optical density (OD) vs. ng/ml of HRP2 in the HRP2 ELISA. Error bars represent the standard
deviation of OD across the replicate assays. The HRP2 threshold of detection of the ELISA = 0.11 ng/ml.
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i.e. the availability of nutrients, temperature and gas com-
position; and parasite strain, as growth rates vary accord-
ing to a parasites origin and the time a parasite has had
to adapt to in vitro culture. The data reported here in
conjunction with the HRP2 antigen modeling, indicates
that undertaking the HRP2 Ag ELISA after 14 days of
culture should result in the identification of all positive
wells, even with parasite replication rates as low as 3 per
cycle. As the method detects HRP2 that has accumulated,
detection of clones also depends on the length of time
since the media was changed prior to the assay. As 89%
of HRP2 is released it the point of schizont rupture [10],
allowing a minimum of 48 hours (which corresponds to
one erythrocytic cycle) between media change and
ELISA, ensures that the HRP2 will accumulate to detect-
able levels.
Conclusions
Parasite detection by HRP2 ELISA is a sensitive and
accurate way of overcoming the rate-limiting step of the
limiting dilution method. Using ELISA allows large scale
limiting dilution experiments to be performed simulta-
neously, thereby increasing productivity. Furthermore,
the method allows culturing to continue after the assay,
a distinct advantage over previously described methods.
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